真武汤联合腹腔化疗治疗脾肾阳虚型癌性腹水的临床效果

Abstract
Figure/Table
References (16)
Related Citation (1)

Download: PDF (0 KB) HTML (34 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the effect of Zhenwu Decoction combined with intraperitoneal chemotherapy in the treatment of carcinomatous ascites of spleen and kidney yang deficiency type.Methods The clinical data of 50 patients with carcinomatous ascites identified as spleen and kidney yang deficiency type treated in our hospital from January 2015 to January 2017 were analyzed.According to the different treatment methods,20 patients in the control group were treated with Cisplatin and Fluorouracil chemotherapy and the rest was classified into the observation group given Cisplatin and Fluorouracil chemotherapy plusing Zhenwu Decoction.T cell subsets,NK cells,clinical efficacy and the incidence of adverse reactions in the two groups were observed.Results The amount of CD4+,CD3+,CD8+,CD4+/CD8+and NK cells,and total clinical remission rate in the observation group were all higher than those in the control group and the incidence of adverse reactions such as hematological toxicity,gastrointestinal reaction,liver function damage,renal function damage,and mucosal ulcer was lower than that in the control group,with a statistical difference(P＜0.05).Conclusion Zhenwu Decoction combined with intraperitoneal chemotherapy in the treatment of carcinomatous ascites of spleenkidney yang deficiency type can improve the organismic immune function with a high remission rate and few adverse reactions,which is worthy of clinical application and promotion.

Key words： Zhenwu Decoction')" href="#">

Zhenwu Decoction Intraperitoneal chemotherapy Spleen and kidney yang deficiency type Carcinomatous ascites

	Service

	E-mail this article Zhenwu Decoction;Intraperitoneal chemotherapy;Spleen and kidney yang deficiency type;Carcinomatous ascites”. Please open it by linking:http://dangdaiyiyao.com/EN/abstract/abstract5043.shtml" name="neirong">
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LUO Jia-hua
	LIU Zhen-hai
	LI Zeng-hui

Cite this article:

LUO Jia-hua,LIU Zhen-hai,LI Zeng-hui. ClinicaleffectofZhenwu Decoction combined with intraperitoneal chemotherapy in the treatment of carcinomatous ascites of spleen and kidney yang deficiency type[J]. 中国当代医药, 2018, 25(11): 145-147.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2018/V25/I11/145

[1]	李寿杰.逐水膏外敷中极穴治疗脾肾阳虚型恶性腹水临床疗效观察[J].实用中西医结合临床，2015，15（12）：25-27.
[2]	卢继福.中西医结合治疗脾肾阳虚型肝硬化腹水的临床观察[J].光明中医，2016，31（23）：3488-3489.
[3]	Yagi Y，Maeda T，Yoshim itsu Y，et al.A case of malignant peritoneal mesotheliom a diagnosed with laparoscopic biopsy[J].Gan To Kagaku Ryoho，2014，41（8）：995-997.
[4]	Tseng TC，Liu CJ，Yang HC.Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers[J].Gut，2015，64（2）：292-302.
[5]	惠红霞，万一元，王晓炜.静脉和腹腔化疗联合热疗治疗晚期胃癌伴腹水的疗效观察[J].中国肿瘤临床与康复，2014，11（08）：945-947.
[6]	邢雪花，王琳，盛莉，等.顺铂或洛铂腹腔化疗联合微波热疗治疗癌性腹水的临床观察[J].中华肿瘤防治杂志，2014，21（17）：1376-1378.
[7]	任玲.新型腹腔引流器结合腹腔化疗治疗癌性腹水疗效观察[J].中国医学创新，2014，11（36）：51-53.
[8]	Wen C，Duan Q，Zhang T，et al.Studies on assessment methods of malignant ascites residue and changes of verapamil concentration in intraperitoneal perfusion chemotherapy[J].Cancer Chemother Pharmacol，2014，74（3）：473-478.
[9]	Sehouli J，Pietzner K，Wim berger P，et al.Catum axomab with and without prednisolone premedication for the treatment of malignant ascites due to epithelial cancer：results of the random ised phase Ⅲb CASIM AS study[J].Med Oncol，2014，31（8）：76.
[10]	黄敏，郝传铮.温补脾肾法联合腹腔化疗治疗癌性腹水的临床研究[J].中医药临床杂志，2015，27（9）：1255-1256.
[11]	Tsubam oto H，Takeuchi S，Ito K，et al.Feasibility and efficacy of intraperitoneal docetaxel adm inistration as salvage chem otherapy for malignant gynaecological ascites[J].J Obstet Gynaecol，2014，14（2）：1-5.
[12]	Singh N，Sifri CD，Silveira FP，et al.Cryptococcosis in patients with cirrhosis of the liver and posttransplant outcomes[J].Transplantation，2015，99（10）：2132-2141.
[13]	于彦召，李纳纳.真武汤治疗脾肾阳虚型乙肝肝硬化腹水 37 例[J].光明中医，2017，32（20）：2952-2954.
[14]	祝玉清，梁宝慧.真武汤联合五苓散治疗脾肾阳虚型肝硬变腹水临床研究[J].河南中医，2016，36（3）：466-468.
[15]	牛红星.真武汤治疗肝癌癌性腹水疗效观察[J].陕西中医，2015，36（7）：841-842.
[16]	华杭菊，陈武进，任丽萍，等.真武汤联合腹腔化疗治疗脾肾阳虚型癌性腹水的临床观察[J].光明中医，2017，32（6）：869-870.